Literature DB >> 22970737

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.

Trevor Baglin1, David Keeling, Steve Kitchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22970737     DOI： 10.1111/bjh.12052

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  38 in total

Review 1.  Recent pharmacological advances for treating venous thromboembolism: are we witnessing the demise of warfarin?

Authors:  Shankar Kumar; John Howell; Christopher Mattock
Journal:  J R Soc Med       Date:  2013-09-11       Impact factor: 5.344

Review 2.  The vexed question of whether or not to measure levels of direct oral anticoagulants before surgery or invasive procedures.

Authors:  Armando Tripodi; Francesco Marongiu; Marco Moia; Gualtiero Palareti; Vittorio Pengo; Daniela Poli; Domenico Prisco; Sophie Testa; Maria Zanazzi
Journal:  Intern Emerg Med       Date:  2018-04-26       Impact factor: 3.397

3.  Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol.

Authors:  Jessica Kepplinger; Alexandra Prakapenia; Kristian Barlinn; Gabriele Siegert; Siegmund Gehrisch; Charlotte Zerna; Jan Beyer-Westendorf; Volker Puetz; Heinz Reichmann; Timo Siepmann; Ulf Bodechtel
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

Review 4.  Monitoring target specific anticoagulants.

Authors:  Barbara A Konkle
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 5.  Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations.

Authors:  Helen Mani; Alexander Kasper; Edelgard Lindhoff-Last
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

Review 6.  Perioperative management of oral anticoagulants: a focus on target-specific oral anticoagulants.

Authors:  Geoffrey D Barnes; Kim A Eagle; James B Froehlich
Journal:  Hosp Pract (1995)       Date:  2014-08

7.  Urgent monitoring of direct oral anticoagulants in patients with atrial fibrillation: a tentative approach based on routine laboratory tests.

Authors:  Giuseppe Lippi; Diego Ardissino; Roberto Quintavalla; Gianfranco Cervellin
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

8.  Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery.

Authors:  Rohi Shah; Nomaan Sheikh; Jitendra Mangwani; Nicolette Morgan; Hamidreza Khairandish
Journal:  J Clin Orthop Trauma       Date:  2020-08-23

9.  Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.

Authors:  Armando Tripodi; Walter Ageno; Marcello Ciaccio; Cristina Legnani; Giuseppe Lippi; Cesare Manotti; Rossella Marcucci; Marco Moia; Benedetto Morelli; Daniela Poli; Agostino Steffan; Sophie Testa
Journal:  Blood Transfus       Date:  2017-09-13       Impact factor: 3.443

Review 10.  Rivaroxaban: a review of its use in the treatment of deep vein thrombosis or pulmonary embolism and the prevention of recurrent venous thromboembolism.

Authors:  Celeste B Burness; Caroline M Perry
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.